Archives
September 2010
- 26: Gujarat’s new policy allows taller hospitals and hotels
- 01: Natco Pharma to launch thalidomide drug lenalidomide (Revlimid) for myeloma in US
- 01: AAD-2004 to treat Alzheimer’s, Parkinson’s and lateral sclerosis coming
- 01: Cesarean deliveries take a peak among first-time mothers in US
- 01: Antiplatelet drug atoxapar cuts blood clotting without bleeding risk: Eisai
August 2010
- 31: Shasun to develop Nanoparticle Biochem’s nano drug NBI-29 for prostate cancer
- 31: OGX-011 doubles life expectancy in advanced prostate cancer patients
- 31: India’s biotech market to touch $8 bn by 2015 growing at 20% yearly: CII-Yes Bank report
- 30: New oral pill CH-4051 shows great promise in rheumatoid arthritis
- 30: India’s Glenmark to test new pain drug GRC 17536 on humans by 2011
- 30: Zydus, Natco launch hepatitis B drug entecavir at half of Baraclude’s cost in India
- 30: More school going teenagers quit smoking in US
- 28: Tasimelteon could provide better sleep for totally blind people: Vanda
- 27: Daily aspirin reduces complications linked to blood pressure in pregnancy: NICE
- 27: Pneumococcal vaccine PCV7 brings down pneumonia hospitalizations
- 27: Probiotic Yakult drinking could cut down diarrhea in kids, finds Indian study
- 26: Ranbaxy’s arterolane cures over 70% patients with drug resistant falciparum malaria in studies
- 26: Antibiotics can be given to pregnant women before Cesarean operations, say US gynecs
- 25: Statin drugs could lower heart attack causing C-reactive protein, says study
- 25: Glutathione using 2B3-101 safely delivers cancer drugs through blood brain barrier
- 25: Anti-virals may be useful in treating chronic fatigue, suggests study
- 25: India’s GangaGen develops bacteriophage antibiotic StaphTame to fight drug-resistant superbugs
- 25: Jet lag pill cures travelers by re-setting body clock
- 25: Cashless medical insurance faces hurdle as companies limit benefits to select hospitals
- 24: ACE-031 to treat deadly muscle wasting disease may get speedy approval: Acceleron
- 24: Droxidopa may treat chronic fatigue disease, says Chelsea Therapeutics
- 24: Once-a-day tablet TAS-108 for resistant breast cancer on way
- 23: 1 Day Acuvue TruEye lenses being recalled in some markets of Asia & Europe due to eye irritation
- 23: Carbidopa/levodopa + entacapone combo (Stalevo) could raise heart attack, stroke risks in Parkinson’s patients
- 21: New drug to treat Epstein-Barr virus linked cancers HQK-1004 coming
- 21: Punjab sets up centres to prevent HIV/AIDs to newborns
- 21: Biocon to launch generic medicines to treat hospital acquired infections
- 21: Internal radiation using SIR Spheres shrinks inoperable liver cancer
- 20: Standalone whole-body oxygen therapy device Oscar approved in US
- 20: Neural stem cell therapy could restore nerve functions in spinal cord injury
- 20: Condoms coated with anti-microbial VivaGel to prevent sexually transmitted infections on way
- 20: Nutra Pharma to launch cobra venom-based pain drug Nyloxin in India
- 19: Stem cells, valproic acid combo could cure paralysis: Study
- 19: Melanoma drug ipilimumab may get fast-track regulatory approval
- 19: New blood test for early detection of ovarian cancer appears foolproof: US researchers
- 19: Lorvotuzumab shows promise as single drug to treat small-cell Lung Cancer: ImmunoGen
- 19: India’s Sun Pharma to launch generic venlafaxine (Effexor XR) with 6 months’ sales exclusivity to treat depression in US
- 18: Oxigon could prevent both amyloid beta and neural damage in Alzheimer’s: Intellect
- 18: Phenylketonuria drug sapropterin advances to final phase of clinical studies
- 18: Day-time sleepiness drug sodium oxybate (Xyrem) risks abuse potential if approved to treat pain: US FDA experts
- 18: Elder Health Care to market cosmetic products from Polo in India
- 18: Thermal device to destroy diseased tissues MTX-180 gets approval in US
- 18: KP106 can cut down side-effects, abuse risk in ADHD treatment: KemPharm
- 18: Reprogrammed stem cells offer promise for Parkinson’s patients
- 18: Outward knee alignment could worsen osteoarthritis
- 17: Seizure drug lamotrigine (Lamictal) ups meningitis risk: US FDA
- 17: Delhi, Gujarat, Haryana to get cheaper female condoms
- 17: Low blood pressure drug midodrine may be recalled in US
- 17: 5-day contraceptive pill ella to go on sale
- 13: Sankara Eye Hospital starts clinic to prevent and treat eye diseases linked to computer vision syndrome in Bangalore
- 13: India supplies free HIV/AIDS medicines to 335,232 patients, says govt
- 13: Non surgical therapy for prostate cancer Sonablate is now at HCG, Bangalore
- 13: Dengue fever scare spreads across New Delhi
- 12: Two-barrel syringe for hemophila drug Xyntha delivery approved in US
- 11: Traditional medicine research body opposes Ayurveda, Unani, Siddha physicians practicing modern medicine in Tamil Nadu
- 11: NACO plans treating drug addicts with pills to prevent HIV/AIDS transmission via needle exchange
- 11: Vaccine to treat Parkinson’s on way
- 11: India’s revised ‘recommended dietary allowance’ (RDA) nutrition guidelines in the works
- 11: 2009 H1N1 flu virus mutation caused rapid spread
- 10: Dengue fever vaccine to prevent 4 strains of diseases underway
- 10: No violations in Bhopal televancin (Vibativ) trial: Quintiles
- 10: Mumbai records highest number of deaths from HIV/AIDS in India
- 10: Potiga (ezogabine), first potassium channel opener drug to treat epilepsy from Valeant may get FDA approval
- 10: Cresp from Dr Reddy’s: long-acting anemia drug darbepoetin alfa (Aranesp) generic in India
- 10: Coconut oil cuts fat; prevents diabetes, says Australian study
- 09: Enzavac single dose injectable vaccine to prevent H1N1 swine flu from Serum in India
- 09: 462 deaths related to testing of experimental drugs on patients in India till mid-2010 alone, show health ministry figures
- 09: HIV/AIDS infection high among pregnant women in Karnataka
- 06: TB vaccine to replace BCG may be 10 years away
- 06: New therapy to increase survival of liver cancer patients coming
- 06: Apollo Hospital conducts heart transplant surgery on a 65 year old American
- 06: Viamtrics to cut down risk of twin and triples through test tube IVF births launched in Lilavati
- 06: Gerteis to boost marketing high-end granulation machines Macro Pactor and Ultra Pactor in India
- 06: Kerala to immunize more doctors and health workers with 34,000 doses of H1N1 vaccine in second round of inoculation
- 06: Tamil Nadu leads population control through family planning in India
- 06: 2 Jan Aushadhi drug stores to supply medicines at half price coming in Kolkata
- 05: India orders probe into death of patients while testing televancin on Bhopal gas tragedy victims
- 05: Bloodless surgery for lung cancer using less radiation RapidArc technology at Yashoda Cancer Institute
- 05: Diabetes risk 50% high among arthritis patients
- 05: India to supply cheap female condoms priced Rs 3.50 nationwide
- 04: IISc join hands with Deakin University to develop safer but highly effective medicine against cancers in India
- 04: Anti-oxidant therapy RTFit to treat alcoholic liver disease in India
- 04: Resveratrol in wine boosts brain power
- 04: Florbetapir dye to pinpoint Alzheimer’s in brain scan coming
- 04: CordLife offers replacement warranty for cord blood banking clients
- 03: Single drug CUD-101 to destroy advanced head and neck, gastric, breast and liver cancers on way
- 03: NACO to supply condoms dhabas, auto workshops and barber shops to prevent HIV/AIDS in Indian villagers
- 03: Female condoms in India get more popular
- 03: Stem cell therapy GRNOPC1 for spinal cord break injury goes on human testing: Geron
- 02: Gay condom Spice Up to hit Indian market
- 02: Madhya Pradesh to tighten rules of drug testing drugs on humans as reports allege ethical violations
- 02: India to study causes of rising HIV infection in kids
- 02: No death from oxytocin-laced vegetables in India: Health Minister
July 2010
- 30: The BeautifulPeople.com helps parents to have good-looking babies
- 30: Cure for Huntington’s disease on horizon
- 30: Delirium heightens death risk in elderly patients
- 30: Sleeping pills not safe for children, says study
- 30: Photodynamic therapy avoids surgery in prostate cancer
- 29: Cord Life expands cord blood banking to Mumbai
- 29: Custom fit knee replacement surgery performed at Fortis Hospitals Bangalore
- 29: Indian firms launch cheaper H1N1 swine flu detection kit
- 29: Herbal cloths to heal diseases getting popular in Kerala
- 29: Turmeric aggravates typhoid caused by Salmonella, say Indian researchers
- 28: Drug to protect radiation attack from nuclear bombs coming
- 28: Vegetables contaminated with dangerous levels of oxytocin hormone, alerts Indian minister
- 28: Emergency contraceptive pills use on rise among Indian women
- 28: Himachal to have biotech incubation centre
- 28: Deadly vivax malaria causes heart attacks in Mumbai
- 28: Once-bimonthly human growth hormone injection to go on human testing
- 28: Palifosfamide (Zymafos) effective to treat sarcomas
- 27: HIV drugs up efficacy of TB drugs in co-infection, finds study
- 27: Stem cell device Celution for breast reconstruction gets EU approval
- 27: India conducts nation-wide survey on leprosy even as fresh cases reported in Pune
- 27: New TB vaccine to replace BCG 10 years away
- 27: Indian AIDS vaccine from Transgene Biotek shows promise
- 27: AEG35156 extends extend survival in liver cancer: Aegera
- 27: India stops TV ads of OTC oral contraceptive pills on TV
- 27: Sankara Netralaya develops infection-free stem cell cure for corneal blindness
- 26: H1N1 mass vaccination in India not professional, says doctors
- 26: Oral soluble film Zuplenz to stop vomiting after surgery, chemo and radiation on sale
- 26: Jevtana shows promise for drug-resistant prostate cancer
- 26: New AIDS drug safer, works better than efavirenz (Sustiva): ViiV-Shionogi
- 23: India makes clinical studies mandatory for Ayurveda, Siddha and Unani medicines
- 22: Glenmark to launch norethindrone (Aygestin) generic pill to treat lack of menstrual flow in US
- 22: Indian HIV/AIDS vaccine to go on 2nd phase of human testing by 2011
- 22: Surgery to correct curved spine scoliosis performed at Fortis Hospital
- 22: Assam to start 24-hour helpline to provide medical aid
- 22: Insurance benefits for Ayurvedic drugs urged in Kerala
- 21: Eisai to export Alzheimer’s drug donepezil (Aricept), anti-ulcerant rabeprazole (Pariet) from India
- 21: Swine flu infections on rise again in India as WHO readies to declare an end to H1N1 pandemic
- 21: DuPond to boost sales of medical packaging material Tyvek in India
- 21: India to check exports of counterfeits; ensure quality of ‘made-in-india’ drugs
- 21: India ups share in global generic market by 8%: Report
- 20: HIV drug consumption to double in India as 1 lakh more patients go for ART
- 20: India to set up public sector animal experimentation centres in Bangalore, Guwahati and Hyderabad
- 20: Bilcare Tech launches anti-counterfeiting device nonClonableID to pharma, agri products
- 20: Eight new medical colleges to come up in Gujarat
- 20: Alferon N injection for hospitalized flu patients goes on trials in India
- 19: DNR PCR test detects HIV/AIDS in infants aged 6 months in India
- 19: US FDA alerts on steroid containing food supplements in India
- 19: Haryana cracks down chemists selling habit-forming drugs illegaly to youths
- 19: Serum to launch single nasal vaccine to prevent both seasonal and H1N1 swine flu vaccines in India early next year
- 19: Prices of life-saving medicines to go up as India plans imposing duty on raw materials
- 16: Manipal hospital starts key-hole bariatric surgery to control obesity
- 16: Glaxo-Pfizer JV offers free access to new HIV/AIDS medicines to low-cost generic makers in poorer nations
- 16: Contrast agent Definity for ultrasound imaging in India
- 16: Indian suspends rosiglitazone (Avandia) studies comparing Actos in diabetes patients on higher heart-risk data
- 16: Use of peripherally inserted catheters can cut down infant mortality: Vygon
- 15: Arthritis to hit 65 crore Indians by 2013, reports
- 15: Maharashtra to install detection device in sonography centres to prevent sex determination and female infanticide
- 15: Manipal on high alert as Japanese encephalitis epidemic breaks out
- 15: Obesity statistics for India: Obesity rising; 20 % school kids are overweight
- 15: New Indian hospitals go green to save energy
- 14: Dr Reddy`s launches generic anti-allergy drug desloratadine (Clarinex) in US
- 14: Arthritis drug leflunomide (Arava) causes severe liver injury, warns US FDA
- 14: Inhaled insulin cuts memory decay in Alzheimer’s patients: study
- 14: Glenmark to market asthma medicine theophylline generic in US
- 14: India may bring in standard model for medical masks
- 13: Insulin delivery implant Cell Pouch System for diabetics on way: Sernova
- 13: BPL to launch mercury-free diagnostic devices in India
- 13: NII researchers develop once-in-3-month insulin to treat diabetes
- 13: Nasal spray Ectoin for allergic rhinitis promising: bitop
- 13: Cochlear Ltd expands operations in India; sets up offices in New Delhi, Mumbai and Bangalore
- 12: MNC drug makers in India stand to gain Q2 2010 on hardening rupee
- 12: India can produce cheaper HPV cervical cancer vaccines: US scientist
- 12: Free ambulance services 24X7 in Himachal Pradesh from October 2
- 12: Sankara Nethralaya to test ISCO’s stem cell therapy CytoCor for blindness in India
- 12: Homoeo medicine Belladona could prevent Japanese encephalitis Virus
- 09: Broad range pneumococcal vaccine Prevenar 13 to prevent pneumonia, meningitis in infants launched in India
- 09: KIMS joins hands with GE & Varian to start advanced radiotherapy centres for cancer patients in rural India
- 09: HCG opens non-invasive heart blood flow imaging device PET-CT
- 09: Swab test predicts baldness risk early, claims Metropolis
- 09: Lipid levels dangerously high among Delhiites: Survey
- 08: Bhopal methyl-iso-cyanate gas tragedy victims made guniea pigs for testing experimental drugs: Reports
- 08: India’s Serum Institute produces cheap meningitis vaccine at Rs 30 per dose
- 08: Indian scientists extract liver cancer drug from babool tree bark
- 08: Ayurvedic, Unani, Siddha herbal products may require safety and efficacy data from human testing in India
- 08: India to screen over 7 crore adults above 30 years of age for diabetes, blood pressure
- 08: Cheap blood test to warn Alzheimer’s risk 10 years early coming
- 08: Breast cancer affects 9 % of men with faulty gene BRCA2
- 08: Tepluzimab to replace regular insulin injections forever found promising in Indian diabetics
- 07: Ultrasound treatment to cure fibroids and tumours in uterus without surgery in Mumbai’s Jaslok Hospital
- 07: Bharat Biotech lines up H1N1 cell culture vaccine HN-Vac launch even as swine flu stages a come back in India
- 06: Drug coated baloons emerging as cheaper and safer option to stents for opening up heart vessel blocks
- 06: Opto Circuits to hire 500 staff in India; boosts medical devices production
- 06: New TB pill rifapentine promises to shorten treatment time: Sanofi
- 06: Libido boosting low-dose testosterone gels may increase heart disease risk
- 06: Glenmark to launch adapalene gel to treat a severe form of acne in US
- 05: Pharma MNCs violates labour laws in India, allege medical reps
- 05: US FDA may start on-site inpections of drug testing centers on humans in India: Report
- 05: SevenHills opens 1,500-bed multispeciality hospital in Mumbai
- 05: 3-minutes heart blood vessel scanner Discovery NM 530C goes operational at Mumbai’s Jaslok Hospital
- 05: Small dose, needle-less polio vaccines on horizon
- 03: Side-effect free nano delivery of common pills and injections by Aphios coming
- 02: Pill-plus oral contraceptive pill boosts sexual desire in women: BioSante
- 02: Nudoxa to treat cancers affecting breast, ovaries and Kaposi’s sarcoma in India
- 02: Bangalore’s NephroLife offers quicker dialysis via GPS tracking of kidney patients
- 02: India to incentivise companies for producing good quality medicines
- 01: Kidney cancer pill tivozanib highly promising: Aveo
- 01: Needle-less device for hemoglobin spot checking Pronto-7 on sales
- 01: Indian political party AGP question effectiveness of cervical cancer vaccines
- 01: Cipla offers free know-how for making cheaper copies of costly cancer medicines to India’s public sector drug companies
- 01: Free HIV/AIDS treatment centre opened in Pune for anti-retroviral therapy (ART)
- 01: Vedanta cancer hospitals coming up in Chattisgarh, Maharashtra, Andhra Pradesh, Madhya Pradesh and Orissa
June 2010
- 30: Thrice-a-week insulin degludec shows promise: Novo Nordisk
- 30: Eisai is hiring 100 staff including scientists to man upcoming R&D centre in India
- 30: Ban on emergency contraceptives i-pill, Unwanted 72 and Option 72 sought on dangers to health, concerns of misuse
- 30: Apollo goes rural; to start hospitals in Karaikudi, Andaman & Nicobar, Karimnagar and Chittoor
- 30: Honey dressing Medihoney Alginate heals chronic wounds faster: Derma Sciences
- 30: Cochlear implant device Nucleaus 5 to cure deafness surgery in KKR ENT Hospital, Chennai
- 30: Quick blood test for hepatitis C virus infection OraQuick to go on sale
- 30: Kerala drug regulator challenges herbal Musli Power Xtra’s claims as impotency medicine in court
- 29: MMV joins hands with AstraZeneca to eliminate malaria from India, worldwide
- 29: Error-free blood glucose testing strips FreeStyle Lite to hit markets shortly: Abbott
- 29: HIV/AIDS spreading fast in Arunachal Pradesh
- 29: Ginger-based medicine Zindol to stop vomiting after chemotherapy in cancer patients promising: Aphios
- 29: Key-hole surgery for hernias at Mumbai’s Lilavati Hospital
- 29: Plant-based medicine Herbal V Hair Care for hair re-growth and cure baldness developed by Indian researchers
- 26: Simplexa test to differentiate influenza A and 2009 H1N1 swine flu virus approved
- 26: No data on heroin, cannabis use among women in India: UN report
- 26: Type 1 diabetes can be reversed through gene therapy: Study
- 25: Menstrual blood banking services in India shortly, says LifeCell
- 25: Cancer of esophagus could be rising in India
- 25: Antigen drug Diamyd to prevent type 1 diabetes coming
- 25: Quality standards for herbal and homeo medicines in India: Ayush Standard Mark and Ayush Premium Mark
- 25: Mobile phone towers not linked to childhood cancer: Study
- 25: Stem cell drug StemEx may replace bone marrow transplant in blood cancer
- 25: Mangalore intensifies campaign against malaria
- 24: sanofi defends Lantus as studies suggest insulin glargine use could raise breast cancer risk in diabetics
- 23: Smaller penis in Indian men leads condom failure; higher HIV infection risk
- 23: Caterpillar fungus Himalayan Viagra no remedy for men’s impotence, say studies
- 23: Blood test to detect AIDS virus shortly after infection Architect HIV Ag/Ab gets approval in US
- 23: Indian researchers from NCBS offer drug leads to reverse defects of autism, mental retardation
- 23: Newborn’s inverted heart chambers defect corrected at Kokilaben Dhirubhai Ambani Hospital
- 23: Tamil Nadu allows ayurveda, siddha, unani practioners to prescribe modern medicine
- 23: Cadila Healthcare’s pill Zyog1 to target both diabetes and obesity goes on human testing
- 22: Marijuana-extract spray to treat severe cancer pain Sativex in markets
- 22: Indian health ministry hires 53,500 male health workers to control and prevent infectious diseases
- 19: Rotavirus vaccines found risky for infants even as India goes ahead including vaccine in immunization programme
- 18: Maharashtra doctors, medical staff shun H1N1 swine flu vaccine shots
- 18: Single flu vaccine Multimeric-001 to fight all influenza virus strains in all seasons underway: BiondVax
- 18: ella (ulipristal) contraceptive pill can be taken upto 5 days after intercourse, says HRA Pharma
- 17: Vitamin D supplements in higher doses risky for infants
- 17: Umbilical cord blood is as effective as bone marrow transplant in blood cancer leukemia patients
- 17: Non-surgical lungs diseases treatment scanner CP EBUS at Fortis Hospital
- 17: Serum to launch cheap, single dose nasal vaccine Nasovac in India
- 17: India supplies sanitary napkins for village girls at Rs 1 per pack to ensure menstrual hygiene
- 16: Spherix’ new diabetes drug D-tagatose (Naturlose) is undergoing clinical studies in India
- 16: Azixa effective to tackle treatment resistance in brain tumours, melanoma: Myriad
- 16: Kerala institute to launch herbal Viagra to treat sexual impotency in men
- 16: Pill to prevent menstrual pain VA111913 may hit markets soon
- 16: India to prevent low-quality drugs imports from Chinese firms
- 15: Refrigeration-free insulin for diabetes patients coming
- 15: NicVax vaccine denies `kick’ to smokers; stops re-starting smoking habit
- 15: Low-dose nano drug HIVCide to stop all HIV types shows promise
- 15: Stem cell-based therapy for recurrent brain tumour approved for patient studies
- 15: Herbal medicine Ampucare for non-healing wounds 100% effective: Venus Remedies
- 14: Drugs side-effects, reactions reporting centres in all medical colleges in India soon
- 14: Diabetic women more prone to cancers of ovary, uterus
- 14: List of rare blood group Oh Bombay phenotype donors in BGS Hospitals registry
- 14: Blood pressure medicines valsartan and losartan may lead to cancer, says study
- 14: Global Hospitals to start multi-organ transplant centre in Mumbai
- 11: Oral pill FTY720 to treat multiple sclerosis approved
- 11: Herbz launches herbal weight loss pill Go Lite in India
- 11: Dengue, rat fever, swine flu spread widely across Kerala; over 25 deaths
- 11: Vaginal ring IPM 015 to stop HIV infection in women during sexual intercourse on way
- 11: India to bring in eligibility norms for surrogate motherhood; curb unethical infertility clinics
- 10: Merck’s MK-4305 drug promising 8-hours sleep for insomnia on way
- 10: Stem cell therapy for spinal chord injuries through tiny puncture by Indian firm Stempeutics
- 10: 1 in 25 Indians prone to heart failure due to defective gene: Study
- 10: Daiichi-Ranbaxy’s anti-blood clot pill Prasita (prasugrel) generic to stop blocks in heart vessels in India
- 10: Quicker, safer radiation therapy 160 Leaf MLC technology for cancer patients in Mumbai’s Jupiter Hospital
- 10: Indus Health Plus offers lab tests at home
- 10: Viagra pills can cause hearing loss, says study
- 09: Most Indian cities are unhealthy, unclean to live: Urban ministry survey
- 09: Cheaper, top-selling medicines to be available for Indian villagers
- 09: Anti-diabetes, obesity injection Victoza (liraglutide) in India @ Rs 4,300
- 09: India to prevent unethical drug studies in humans by pharma companies
- 09: Macugen injection may restore sight in blindness due to diabetes
- 08: Leukemia vaccine GVAX CML promising: BioSante
- 08: Chewable gel to stop nicotine addiction soon in India
- 08: Blood plasma fractionation centre in Chennai soon
- 08: Drugs to prevent organ failure deaths from blood poisoning on cards
- 08: Anti-HIV pills taken immediately after sexual intercourse stops AIDS virus infection: Study
- 08: Sex hormone estrogen patches pose low stroke risk: Study
- 07: Bladder cancer vaccine shows promise, says Celldex
- 07: 20,000 public health workers vaccinated against H1N1 swine flu in Tamil Nadu
- 05: New Indian TB pill cuts short treatment time by half, claim PERD reseachers
- 05: Drug to treat heroin addiction Vivitrol may hit markets soon
- 05: Urine test for early detection of autism on the horizon
- 04: Levodopa skin patch for Parkinson’s enhances treatment outcome
- 04: Breast cancer prevention vaccine underway
- 03: Vaccine ICT-107 more than doubles survival time for deadly brain cancer patients
- 03: Urine test to correctly spot prostate cancer Progensa PCA 3 coming
- 03: Pocket ECG device eUNO for instant access via Blackberry phones in India
- 03: Salmetrol can worsen asthma; even lead to death
- 03: Heart-risk diabetes drug rosiglitazone (Avandia) being tested on Indian patients: Reports
- 03: Herbal pill CardioCholesterol to tone up heart muscles in India
- 03: Indian bio drug Avent to treat arthritis safe, says Avesthagen
- 03: Healthcare spend lowest in India @ 0.36% of GDP
- 02: New drug nucleozin may fight H1N1, H3N2, and H5N1 flu viruses
- 02: Nano delivery of cancer drugs increases effect by 5 times
- 02: Food supplement lozenges Maxisal for dry mouth launched: Amarillo Bio
- 01: New surgery for severe heart defects in infants shows promise
- 01: Antidepressants like Paxil, Effexor may lead to spontaneous abortion
- 01: Test to detect bladder cancer Cysview coming
- 01: Smaller pill packs and strips may soon be available in Indian drug stores
- 01: Gel to prevent HIV, herpes infections in women VivaGel may hit markets soon
May 2010
- 31: Overweight girls must lose weight before 18 to cut diabetes risk
- 31: Herbal pill to quit smoking Quitobac by Birla Veda launched
- 31: Single hole laparoscopic obesity surgery in India
- 31: Inhaled apomorphine cures erectile dysfunction in minutes, claims Vectura
- 31: New brain cancer vaccine CDX-110 stops tumour growth in 70% of patients
- 31: Glucose-intolerance in diabetes may be cured through blocking protein in pancreas
- 29: Pills that can stay upto 24 hours in stomach for absorption coming in India soon
- 29: High vitamin K intake may cut diabetes risk
- 29: Treatment-resistant depression therapy VNS shows long-term effect: Cyberonics
- 28: India makes cheaper generic drugs prescription compulsory in public hospitals
- 28: MNC drugs’ prices in India to rise
- 28: Omeprazole,lansoprazole, pantoprazole and rabeprazole cause bone fractures; may face hurdle in India
- 28: First oral endometrosis drug elagolix shows promise
- 28: Serum Institute develops injection-free nasal spray H1N1 vaccine for Rs 150
- 28: New gene therapy drug brings down 80% of bad LDL cholesterol in a single dose
- 28: Pill to cure chicken pox infection soon in India
- 27: Stem cell hospital to treat osteoarthritis, foot ulcers, heart disease coming up in Bangalore
- 27: Rapid home HIV test kit VScan in India
- 27: Safe drugs targeting only cancer cells around corner
- 26: Stem cell therapy for stroke NTx-265 flunks in patient studies
- 26: Virus linked to diabetes in children: study
- 26: Death during childbirth high among backward castes of Indian women: Oxfam
- 26: Hepatitis C drug teleprevir cures 75% virus infection, says Vertex
- 26: Cheaper TB-drug rifampicin can stop tissue damage diseases in diabetics, claim Indian researchers
- 26: Blood sugar controlling pill metformin leads to vitamin B-12 deficiency disease in diabetics
- 26: Hip replacement surgery cost lowest in Indian hospitals
- 26: Kerala’s private hospitals can now store blood; no fee for permits
- 25: Chewable coenzyme Q10 pills Ecozyme to boost immunity against cancer, Parkinson’s in India
- 25: Blood banks in Andhra Pradesh on HIV alert
- 22: Abbott deal: Piramal to stop selling generic medicines in India for next 8 years
- 22: Abbott aims No 1 slot in Indian drug market combining Piramal’s formulations portfolio
- 21: Wockhardt’s Q4 FY 2010 revenue drops
- 21: Testing eyes for amyloid-beta could predict Alzheimer’s in early years
- 21: Rituximab (MabThera, Rituxan) doubles survival of lymphoma patients: Roche
- 20: Glenmark stops oglemilast (GRC3886) development programme for COPD & asthma with Forest
- 20: India’s Strides gets tentative US FDA approval for HIV pill abacavir (Ziagen) generic under PEPFAR
- 20: Once-a-day painkiller aceclofenac injection by Venus Remedies gets Indian patent
- 20: HDL cholesterol drug CER-001 shows promise in high risk heart patients: Cerenis
- 20: PregLem’s oral drug Ulipristal (Esmya) more effective to treat fibroids in uterus
- 20: Labetalol (Normodyne, Trandate) linked to attention deficit hyperactivity disorder (ADHD) in babies, says study
- 20: Female Viagra Flibanserin works better for women with low sexual desire: Boehringer
- 19: Human reovirus-based drug Reolysin has potential to tackle Kras mutant colorectal cancer: Oncolytics
- 19: Rajasthan hospitals to prescribe cheaper generic medicines
- 19: No plan to sell promoter’s stake, says Piramal Healthcare
- 19: Prices of cough, vitamin syrups may be revised in India soon
- 19: Ranbaxy withdraws mirtazapine, sertraline pills from Britain, Ireland & Denmark
- 19: India revokes patent granted to Roche’s Valcyte (valganciclovir): Reports
- 19: Metronidazole injection supplied by India’s Claris Lifescience recalled in US
- 14: Pfizer expands generics pact with India’s Strides to include more injectables, more markets
- 14: Dr Reddy’s to launch generic tacrolimus (Prograf) in US
- 14: Herpes zoster (shingles) vaccine Zostavax safe for elderly people, says Merck
- 14: Antibody drug to treat LDL cholesterol REGN727 promising: Regeneron
- 14: India’s cancer drugs market grows faster @ 16% per year; to reach $559 m by 2015 –Reports
- 14: Sexual impotency drug alprostadil (Vitaros) heals deep tissue wounds four times faster, says Nexmed
- 13: Zoraxel erectile dysfunction drug directly affects brain: Rexahn
- 13: Strides Arcolab’s vecuronium bromide injection gets approval in US
- 13: Aurobindo gets tentative approval for rosuvastatin (Crestor) generic pills in US
- 13: Two of every three diabetics in Delhi have uncontrolled diabetes: Sanofi study
- 12: Oral corticosteroid beclomethasone orBec to treat gastrointestinal disease enters crucial phase of clinical studies: Soligenix
- 12: Zydus Cadila to launch India’s first H1N1 swine flu vaccine VaxiFlu-S
- 12: Suven’s neurodegenerative leads get Canadian & Eurasian patents
- 12: Valacyclovir (Valtrex) generic windfall sales in US bolster Ranbaxy’s Q1 2010 revenues to Rs 961 cr
- 12: Unichem reports 7% growth in FY2010; oveseas sales drop
- 12: Strides Arcolab to launch bacitracin injection in US by third quarter of 2010
- 12: India may bring vaccines under price control: Reports
- 11: Abbott to market Zydus Cadila’s 24 generic products to 15 emerging markets
- 11: Once-daily indacaterol + glycopyrronium inhaler for COPD reaches phase 3 trials: Sosei
- 11: Regorafenib to treat metastatic colorectal cancer in advanced patient studies:Bayer Schering Pharma
- 10: Jubilant Organosys reports 48.8% jump in net profits in FY2010
- 10: Low-dose morphine + oxycodone combo MoxDuo to treat severe pain shows promise: QRxPharma
- 10: Pfizer may forge generics supply pact with India’s Cipla: Reports
- 10: Fat-tissue derived stem cells improve heart function in severe heart attack patients: Cytori
- 10: India sales drive Piramal’s FY2010 profits over 50%
- 08: Cipla buys 2 manufacturing facilities; FY2009-2010 net sales soars by 8%
- 08: Cadence seeks marketing approval for acetaminophen IV (Ofirmev) in US
- 08: RestoreSensor no-drug device that stops chronic pain through spinal cord stimulation in clinical studies: Medtronic
- 08: Estrogen-progesterone oral contraceptive pill Natazia (estradiol+dienogest) in US : Bayer
- 08: Anti-cervical cancer programme using HPV vaccine Gardasil in Bhutan
- 07: Veeda to conduct phase 1/2 clinical trials on Siogen’s doxorubicin nano drug
- 06: Dr Reddy’s posts Rs 1.7 billion net profits in Q4 2009-2010; US sales drop
- 06: Hepatitis c virus could turn resistant against Vertex’ teleprevir
- 06: India makes registration of hospitals and clinics compulsory
- 06: Par to market Glenmark’s ezetimibe (Zetia) generic in US
- 06: Novartis promotes imatinib (Gleevec) for unapproved dosages to treat gastrointestinal tumours (GIST), myelogenous leukemia (CML): Warns US FDA
- 06: Stromal cell-derived factor-1 drug NOX -A12 can treat various cancers: Noxxon
- 05: Alvogen to market Orchid Pharma’s CNS and osteoporosis formulations in US
- 05: Overseas sales boost Lupin’s Q4 2009-’10 net by 35.5%
- 05: Stem cell treatment for type 1 diabetes Prochymal by Osiris coming
- 05: Humira to be largest selling drug with $10 bn sales; Teva among top 10 by 2016
- 04: Prostate cancer drugs such as Zoladex, Eligard, Lupron may risk diabetes, death: USFDA
- 04: Rifaximin (Xifaxan 500) antibiotic can treat irritable bowel disease, says Salix
- 04: Azilsartan is superior to olmesartan (Diovan) and valsartan (Benicar) in controlling blood pressure, claims Takeda
- 04: Obese men may have low sex hormone testosterone levels, reduced libido
- 03: Alvogen to start clinical trial services in India by launching Norwich Clinical
- 03: CTP tech boosts interferon beta potential several times, cuts down dosage: Prolor
- 03: Glenmark licences out diabetic neuropathy pain drug molecules to Sanofi-Aventis
- 03: Granules India to launch metformin 1000mg generic pills in US
- 03: Provenge therapeutic vaccine to cure castrate-resistant prostate cancer in US
- 01: India to supply cancer drugs at discounted rates through Jan Aushadhi stores
- 01: Zydus to market prostate drug tamsulosin (Flomax) generic in US
April 2010
- 30: Biocon’s is hiring upto 1000 staff; FY2010 net grows by 22%
- 30: Placental stem cells safe to treat limb ischemia, says Pluristem
- 30: Shantha Biotech recalls children’s vaccine Shan 5 from global markets after safety concerns: Report
- 30: Lucentis (ranibizumab) could treat diabetic blindness, says new study
- 29: Cadila Healthcare reports 67% peak in FY2010 net profits; offers 100% dividend
- 29: Gonorrhea could go incurable as bacteria turn resistant to antibiotics: WHO
- 29: Cervical cancer vaccine Gardasil tested in children before studying in adults: Indian health ministry official
- 29: Prasugrel to prevent blood clots in heart vessels launched in India by Glenmark
- 29: AstraZeneca illegally promoted quetiapine (Seroquel) to treat aggression, anger; pays $510m fine in US to
- 28: Suven’s 5-HT compounds to treat Alzheimer’s, schizophrenia get more patents from New Zealand and India
- 28: Non-drug medical device Alair to treat severe asthma by Asthmatx approved in US
- 28: Ulcer drug lansoprazole (PrevOnco) could treat liver cancer: NexMed
- 28: Natco’s Albupax has high toxin levels, says India’s central drug testing lab
- 27: Cipla to market India’s stem cell drug Stempeucel for leg ischemia by Stempeutics
- 27: TCG Lifesciences expands discovery research services through Australian firm Mantrax Ventures
- 27: Glenmark to launch norethindrone (Nor-QD) generic contraceptive pill in US shortly
- 27: Alembic chairman Chirayu Amin to head Indian Premiere League (IPL)
- 27: Don’t mix premature ejaculation pill dapoxetine (Priligy) with alcohol, alert experts
- 27: Sun Pharma to stop oxaliplatin (Eloxatin) generic sales in US following court order
- 27: Blood test Allomap helps cut down biopsies in heart transplant patients: XDx
- 26: Unani medicine effective in treating vitiligo: Indian studies
- 26: Rural malaria blood testings to become easier as WHO approves more rapid diagnostic tests to aid malaria fight
- 26: Stem cells to treat in neuronal ceroid lipofuscinosis (Batten disease) is underway
- 24: Pyronaridine-artesunate combo pill Pyramax by Korean firm Shin Poong is as effective as Coartem, claims study
- 24: Liraglutide injection (Victoza) more effective than sitaglipin (Januvia) to control blood glucose; has less risk of hypogycemia: Study
- 24: Piramal beefs up anaesthetics portfolio by acquiring Bharat Serums’ injectables business
- 24: AFFiRiS’s Alzheimer’s vaccine AD02 to be studied in European patients
- 23: Siro expands base in Asia-Pacific region through forging pact with Taiwan-based Virginia
- 23: Needle-free vaccine technology VRx2 by Mystic receives US patent
- 23: Suven Life gets 3 more Australian patents for neurodegenerative disease leads
- 22: Prana Biotech’s new drug PBT2 to be tested in Alzheimer’s patients
- 22: Telcagepant and topiramate offer new hope for migraine sufferers, says study
- 22: Glenmark moves closer to launch ezetimibe (Zetia) generic pill as US court rejects most of Merck’s patent claims
- 22: Pollen-derived Oralair to treat allergic conjunctivitis is promising: Stallergenes
- 21: Strides Arcolab’s generic metoprolol injection (Lopressor) gets US FDA approval
- 21: Lung cancer therapy prediction test Pulmotax effective, claims Clarient
- 21: Health insurance penetration to drive India’s pharma formulations market upto 17% growth in FY2010: RNCOS report
- 21: Intranasal vaccine for hepatitis B is in clinical trials: NanoBio
- 21: Hypoxia-activated prodrug TH-302 could help reducing pancreatic tumour: Threshold
- 20: Lupin starts shipping anti-depressant imipramine (Tofranil-PM) generic pills to US
- 20: Matrix Lab’s HIV drug diadanosine (Videx EC) generic pills get US FDA approval under PEPFAR
- 20: Cipla to launch low-cost misoprostol 600mg (MisoProst) to treat bleeding after childbirth in India
- 20: RNAi drug to treat colon polyps CEQ508 in safety studies: Sequent
- 20: Emerging markets including China and India to propel global pharma sales growth to $1.1 trillion by 2014: IMS
- 20: Leprosy still afflicts Indian states of West Bengal, Bihar, Jharkhand and Chhattisgarh
- 19: Strides Arcolab to launch generic Mesna (Mesnex) injection in US market shortly
- 19: Elder Pharma is hiring 1,000 sales staff to tap India’s rural market: Reports
- 19: Dr Reddy’s generic risperidone pills withdrawn in US on quality concerns
- 17: Eli Lilly launches Forteo delivery pen for osteoathritis in India
- 17: Gardasil study: Death of 6 girls not due to vaccine failure, says Indian minister
- 17: Once daily oral drug ENMD-2076 to treat ovarian cancer in human studies: EntreMed
- 17: Dr Reddy’s launches Dose Counter Inhalers – metered dose inhaler (MDI) – in India
- 16: ImmunoGen & Roche ready for early filing for highly potent breast cancer drug trastuzumab-DM1
- 16: Vaccine to fight tuberculosis in HIV infected people coming: Crucell & Aeras
- 16: MicroRNA targeting oligonucleotides could improve insulin resistance
- 15: Hepatitis C drug VX-222 lowers viral levels in early human trials: Vertex
- 15: Once-a-day lixisenatide reduces HbA1c levels in diabetes: sanofi-aventis
- 15: Amoxicillin and clavulanate suspension recall may further strain Ranbaxy-US FDA relations
- 14: Liquid immunoglobulin (Gammagard) helps preventing brain shrinkage in Alzheimer’s patients, claims Baxter
- 14: Suven Life receives Japanese patent for CNS lead
- 14: Aurobindo’s generic ondansetron (Zofran) pills gets US approval
- 14: Gennova Bio launches biogeneric pegfilgrastim (Pegex) in India
- 14: Obeticholic acid cuts down serum alkaline phosphatase levels in cirrhosis: Intercept
- 14: Rural sales to drive India among top ten global pharma markets by 2020: PwC
- 14: Venus to launch cancer detection test VRP 1620 (endothelin) in India soon: Reports
- 14: Glenmark may get 180-day exclusivity for anti-malarial Malarone generic after patent dispute settlement with Glaxo
- 14: Dextromethorphan/quinidine (Zenvia) is safe to treat pseudobulbar affect: Avanir
- 14: Oral pill to treat multiple sclerosis Gilenia by Novartis under regulatory review
- 14: Antifungal itraconazole can fight cancerous tumours: Study
- 13: Transplant organ rejection drug Prograf (tacrolimus) launched in India: Astellas
- 13: Avesthagen to manufacture biogenerics Avent and Avdesp in Malaysian firm Inno Biologics
- 12: New stent to treat abdominal aneurysm Incraft from Cordis is coming
- 12: Lymphoma drug pixantrone (Pixuvri) needs more safety data: US FDA tells Cell Therapeutics
- 10: Diabetes drug exenatide (Byetta) could cause cancer: US FDA
- 10: Reovirus drug Reolysin in combo with Avastin shrinks cancer tumous: Oncolytics Biotech
- 10: Aurobindo’s generic venlafaxine (Effexor) pills to treat depression in US
- 10: Indibulin (Zybulin) pill to treat metastatic breast cancer in human trials, says Ziopharm
- 09: Indian API suppliers see red in new EC proposal mandating inspection of facilities exporting to Europe
- 08: New antibiotic CB-183,315 to treat clostridium diarrhea in human trials: Cubist Pharma
- 08: Sun Pharma to launch depression generic bupropion (Wellbutrin SR) in US
- 08: Jaiva to trial Radient’s new cancer vaccine combination immunogene therapy technology in India
- 08: India suspends Merck’s cervical cancer vaccine Gardasil study after deaths of four girls in Khammam district
- 08: Cipla to launch generic sorafenib (Nexavar) at one tenth of Bayer’s price in India
- 07: Bharat Serums & Vaccines receives funding from Malaysian firm OrbiMed
- 07: Pfizer to find new drugs to treat stomach, liver, head & neck cancers specific to Asia: Reports
- 07: Menstrual blood stem cells could treat stroke damage: Cryo-Cell International
- 07: Bafetinib oral pill has potential to treat advanced prostate cancer: CytRx
- 07: Bupivacaine (Eladur) skin patch for low back pain in human trials: Durect
- 07: Dishman expands API manufacturing capacity; to raise $17 million funds through bonds
- 06: Insulin cell implant Diabecell for type 1 diabetes to go on human studies in New Zealand
- 06: Daiichi seeks Japanese approval for once-daily blood clotting pill Edoxaban
- 06: Biodegradable patch TachoSil to control surgical bleeding to hit US market
- 06: Parexel launches e-clinical solutions platform for late phase trials
- 06: Inhaled ciprofloxacin to treat bronchiectasis from Aradigm may hit markets soon
- 06: Indian firms stand to gain as US generic market is forecast to grow at a CAGR of around 9% during 2010-2012
- 06: Cobalamin-based oral insulin by Access for diabetes type 2 is coming
- 05: Biocon buys Cuban partner CIMAB’s stake in Biocon Biopharma
- 05: AstraZeneca plans to double workforce in India
- 02: Debt-hit Wockhardt calls off nutrition biz sale deal with Abbott
- 02: Trivalent flu vaccine effective against H1N1 A swine flu and H3N2 strains: Novavax
- 02: Antidepressants and monoclonals help US pharma sector weather depression: IMS Health
- 02: Ulipristal emergency contraceptive prevents pregnancy upto 120 hours
- 02: Carglumic acid (Carbaglu) by Orphan approved for treating high ammonia levels in blood
- 02: Apadenoson (Stedivaze) safe in asthma, COPD patients: Clinical Data
- 02: Type-2 diabetes oral pill Saxagliptin launched in India
- 01: Glenmark’s moexipril generic tablets to treat blood pressure get US FDA approval
- 01: Parkinson’s medicine Stalevo could lead to prostate cancer: US FDA
- 01: Varicose vein injection polidocanol (Asclera) approved in US
- 01: Ranbaxy boosts sales team by 50%; to focus on Indian rural market
March 2010
- 31: Dr Reddy’s issues six bonus debentures for every one share
- 31: Davunetide increases cognitive functions in schizophrenia: Allon
- 31: Oral pill to treat advanced gastric cancer tesetaxel by Genta is around the corner
- 31: Acetylcysteine (Acetadote) could prevent liver failure: Cumberland
- 31: SciClone’s SCV-07 delays oral mucositis caused by cancer therapy
- 31: India’s Indoco in supply pact with Aspen on generic ophthalmic drugs for emerging markets
- 30: Reolysin shows promise in lung cancer, says Oncolytics
- 30: No plan to delist Ranbaxy from Indian bourses: Daiichi
- 30: Parenteral Biotech to market Sinovac’s flu vaccines in India
- 30: Aiko Bio’s constipation drug Aiko-150 completes phase 1 human studies
- 29: Suven wins another EU patent for new molecule with potential to treat Alzheimer’s disease
- 29: Autism drug KM-391 shows promise: Cellceutix
- 29: Mipomersen can cut cholesterol in high risk patients: Genzyme and Isis Pharma
- 29: Non-alcoholic liver disease drug in phase 2 studies, says Immuron
- 29: Ranbaxy in technology pact with Pfenex to develop generic biotech drug
- 27: Single drug therapy for hepatitis C Nov-205 by Novelos is coming
- 26: Chembio’s oral fluid test for HIV detection approved by USAID
- 26: Glenmark’s plaque psoriasis ointment calcipotriene (Dovonex) generic gets US approval
- 26: APD916 to treat sleep-wake disorder narcolepsy in human trials, says Arena
- 26: India’s Glochem-supplied clopidogrel (Plavix) generic to be recalled in Europe
- 26: Indian court allows Ranbaxy to sell generic entecavir (Baraclude) for hepatitis B for now
- 25: Thymus cancer drug belinostat undergoes clinical studies: Spectrum Pharma
- 25: Bayer alleges patent violation on Cipla’s sorafenib (Nexavar) generic; moves court again
- 25: Lupin launches knee-joint injection Hyalgan (hyaluronate) for osteoartritis in India
- 25: Gedeon Richter forges alliance with Intas Pharma’s research arm Astron for generic supply
- 24: Pevion’s vaginal candidiasis vaccine Pev7 in human trials
- 24: Cholesterol drug simvastatin brands in India may face trouble as US FDA warns of muscle weakness
- 24: Heplisav is as safe as Engerix-B in preventing adult hepatitis B, suggest Dynavax study
- 24: Adult stem cells for stroke treatment may soon be tested in humans: Stemedica
- 24: Indian researchers develop 1 hour H1N1 swine flu blood test
- 24: Canadian approval for Aurobindo’s generic topiramate (Topamax) pills
- 23: Breast cancer vaccine Stimuvax by Merck could lead to brain infection; trials suspended
- 23: Rotavirus diarrhea vaccine Rotarix by GSK may contain pig virus, warns US FDA
- 23: Piramal Healthcare to promote oral contraceptive i-pill
- 23: Clinical trial deaths increasing in India: Reports
- 23: Lupin’s generic eszopiclone (Lunesta) may be approved to treat sleeplessness in US
- 23: 17 emerging markets including India to contribute nearly half of global pharma industry growth by 2013: IMS Health
- 23: BIM 23A760 to treat gigantism is undergoing safety studies in humans: Ipsen
- 22: Stem cell therapy for blindness in elderly is underway
- 22: Endo Pharma joins hands with Syngene to develop biotherapeutics against cancer
- 19: Teva buys out Ratiopharm for €3.63 bn; climbs on to list of top-notch drug firms
- 12: Methylnaltrexone (Relistor) pills to treat constipation to go on crucial phase of clinical studies, says Progenics
- 12: Bayer looks to double workforce in India; targets to be among top 10 by 2015
- 12: Oral contraceptive pills could help women live longer; cut heart disease, cancer risks: Study
- 12: Stem cell-based vaccine against brain cancer improves survival:ImmunoCellular
- 12: Bayer’s cipro inhaler to treat cystic fibrosis may get priority review in US
- 11: Indian herbal drug Ayusrem can treat H1N1 swine flu: Researchers
- 11: Intravenous macrolide antibiotic CEM-101 to go on clinical studies soon: Cempra
- 11: Scivanta Cardiac Monitoring System measures heart performance more accurately: Scivanta Medical
- 11: Fentanyl spray could relieve breakthrough cancer pain in five minutes: Insys
- 11: India’s Torrent Pharma to supply 18 generic drugs to AstraZeneca for 9 emerging markets
- 10: Multifocal cataract implant lens Tecnis approved for use: Abbott
- 10: Plant-based psoriasis drug Tinefcon safe in human trials, says Piramal Life Sciences
- 10: GE Healthcare plans to make Bangalore hub of computed tomography (CT) imaging system production for south Asia
- 10: Personalized kidney cancer immunotherapy AGS-003 shows better survival benefits than interferon alfa: Argos
- 10: Merkel cell carcinoma drug IMG901 gets special status in US, EU
- 09: Natco to relaunch generic nano drug Albupax to treat breast cancer after recall on toxicity fears
- 09: D-Pharm’s drug DP-b99 to control stroke damages could hit markets by 2013
- 09: Serum Institute lines up H1N1 vaccine Fluvac launch for May
- 09: Tomato extract product Fruitflow can cut blood clot risks with no side-effect of aspirin, claims Provexis
- 09: Once-weekly immunoglobulin under skin injection Hizentra for primary immunodeficiency approved in US: CSL Behring
- 08: India readies for H1N1 mass vaccination against swine flu as Sanofi Pasteur completes safety trials
- 08: Eight-day otelixizumab injection by Tolerx could offer a potential cure for type 1 diabetes
- 08: Ocrelizumab could cause deaths in rheumatoid arthritis patients; Roche, Biogen-Idec suspends clinical trials
- 08: Synthetic matrix for scaleable growth of human embryonic stem cells launched: Geron & Corning
- 08: Tumour necrosis factor alpha drug (TNFerade) suppresses cancer spreading: GenVec
- 05: Antisense drug ISIS-SOD1Rx to treat amyotrophic lateral sclerosis (Lou Gehrig’s disease) goes on human studies: Isis
- 05: Diagnostic test to detect skin cancer melanoma by Abbott and GSK is underway
- 05: Apixaban superior to enoxaparin (Lovenox) in preventing blood clot in veins, cuts bleeding: Pfizer-BMS study
- 05: Intas Pharma to study Amarillo’s oral interferon-alpha lozenges in Indian flu patients
- 05: Aurobindo launches separate contract manufacturing services division AuroSource
- 05: Genital herpes vaccine ImmunoVEXHSV2 in human trials: Biovex
- 04: Neuralieve’s device treats migraine headaches without medicine, says study
- 04: Weight loss and physical activity can prevent diabetes: Study
- 04: Refractory prostate cancer drug cabazitaxel increases survival rates in patients: Sanofi-Aventis
- 04: Shire to supply new Gaucher disease drug VPRIV (velaglucerase alfa) through easier access programme
- 03: Alzheimer’s drug Dimedon from Pfizer and Medication fails in crucial clinical study
- 03: Abbott and Enanta develop three new drugs to treat hepatitis C
- 03: Aurobindo’s cefuroxime antibiotic pills get Canadian approval
- 03: Panacea Biotech to supply egg-derived H1N1 vaccine to government as India reports 1376 deaths from swine flu as on March 2, 2010
- 03: US FDA stops Ranbaxy’s generic tamsulosin (Flomax) due to poor compliance of GMP in manufacturing plants
- 03: India tightens regulations on stem cell research
- 02: MNC Becton Dickinson plans to hire 100 people a year in India
- 02: Glenmark to market generic ropinirole (Requip) to treat Parkinson’s in US
- 02: Day-time sleep linked to diabetes, claims study
- 02: Stem cells to treat heart attack; stop limb amputation by Stempeutics may be lauched in India in 2 years
- 01: Indian Supreme Court refuses to stay Cipla’s Nexavar (sorafenib) on Bayer’s plea
- 01: Ariad’s new drug AP24534 could offer hope for resistant leukemia
- 01: Avila’s protein silencing drug AVL-181 shows promise in hepatitis C infection
- 01: Serum Institute begins clinical studies on Lipoxen’s long-acting EPO drug ErepoXen in India
- 01: New treatment of baldness Platelet Rich Plasma therapy to go on clinical studies: Nanogen
February 2010
- 26: Hepatic encephalopathy drug rifaximin (Xifaxan) may get approval in US, says Salix
- 26: OneTouch blood glucose test strips recalled by LifeScan Canada for faulty reading
- 26: Milliprobe to detect mycoplasma in bio manufacturing launched: Millipore
- 26: Indian medical devices market gets a booster dose from Union Budget 2010-11
- 26: Screening test to detect autism risk in children may reach markets soon: Transgenomic
- 25: Nevirapine oral suspension pills by Aurobindo gets tentative approval in US
- 25: Kindney transplant drug belatacept by BMS may cause fatal side-effects, say US FDA reviewers
- 25: India reports 1366 deaths from H1N1 swine flu infection as on 25th Feb, 2010
- 25: Sun Pharma to launch generic doceferez (Toxotere) in Europe
- 25: Indian pharma market zooms to US 21.83 billion (Rs 1,00,611 cr.) in 2009-10
- 24: PNH treatment eculizumab (Soliris) @ $409,500 a year is world’s costliest medicine
- 24: Interleukin 17E could treat skin, breast, colon, pancreatic, lung cancers: Lorus
- 24: Pfizer eyes Dr Reddy’s Rs 1000 cr branded generics business: Reports
- 24: Saquinavir and ritonavir HIV drug combination may lead to serious heart problems, warns US FDA
- 24: Waters develops eco-friendly supercritical fluid chromatography columns Viridis
- 24: Blood test to find sex of fetal baby SensiGene launched by Sequenom
- 23: Inhalable antibiotic aztreonam (Cayston) approved for cystic fibrosis in US: Gilead
- 23: Device to treat sleep apnea by ImThera in clinical trials
- 23: Bevacizumab (Avastin) has no use in stomach cancer: Roche study
- 23: US FDA safety alert could threaten sales of Indian salmetrol brands to treat asthma
- 23: Intravenous immunoglobin could offer prevention against Alzheimer’s: Octapharma
- 22: Vaccine to prevent diabetes Diamyd in final phase of clinical studies
- 22: Plaque psoriasis patients could develop resistance against adalimumab (Humira), says study
- 22: Duloxetine (Cymbalta) can cure low back pain: Eli Lilly
- 22: Prices of antibiotics like Mox, Augmentin, Sporidex, Zef to go up by 50% in India
- 15: Max Neeman expands key-hole surgery devices trial services in India
- 15: AstraZeneca bolsters Nexium lawsuit against Lupin alleging violation of 3 new patents
- 15: Shionogi seeks approval for injectable peramivir (Rapiacta) to treat severe flu in children
- 15: Interferon alpha-2b cream to treat HPV cervical cancer, genital warts is on trials: Helix
- 15: Pain clinic opened at Manipal Hospital, Bangalore
- 12: Stem Cell Therapeutics’ ischemic stroke drug NTx-265 is undergoing patient studies in India
- 12: Spectrum to launch blood cancer drug Belinostat in India
- 12: Chickenpox vaccines prevent illness even after exposure to virus, study finds
- 12: India’s Bharat Biotech is developing chikungunya vaccine: Report
- 12: Rajasthan to launch low-cost medicines shops alongside public hospitals
- 12: Plant-based Parkingson’s drug Cogane enters clinical studies, says Phytopharm
- 11: Olmesartan (Benicar) approved for treating blood pressure in kids in US : Daiichi Sankyo
- 11: Huge opportunities for Indian pharma firms as global generic drug market peaks all time high to $83 bn in 2009
- 11: Single dose kala azar (leishmaniasis) drug amphotericin B liposome cures 90% patients in India: Study
- 10: Once-a-month diabetes drug Xoma 052 in dosing studies
- 10: Stem cells to treat heart attack, stroke, bowel disease Multistem by Athersys get US patent
- 10: India to revise clinical trials registry as per WHO standards
- 10: Morphine + oxycodone combo MoxDuo to control severe pain is completing clinical studies: QRxPharma
- 10: Bayer may move Supreme Court on sorafenib patents even as Cipla prepares to launch generic Nexavar in India
- 09: Dermapace to treat severe burns without surgery, grafts show promise, says Sanuwave
- 09: Strides Arcolab wins US FDA approval for generic labetalol (Trandate) injection to treat blood pressure
- 09: Heplisav vaccine could offer immunity against hepatitis B in two doses: Dynavax
- 09: Preventive vaccine against HIV/AIDS to be tested on patients soon: GeoVax Labs
- 09: Pfizer’s cough syrup Corex top brand; Cipla no.1 company in India during 2009: ORG IMS
- 08: Lupin gets generic amlodipine/benazepril (Lorrel) pills for hypertension in US
- 08: Allosteric modulator ADX71943 shows promise in osteoarthritis pain: Addex
- 08: Indian firm Troikaa may win US patent for diclofenac injection (Dynapar AQ) technology
- 08: Natalizumab (Tysabri) risk of deadly brain infection higher with more doses in multiple sclerosis, warns US FDA
- 08: Stem Cell reprogramming technology iPSC by Fate Therapeutics gets US patent
- 05: Ballabgarh villagers in Haryana have lowest Alzheimer’s risk: Report
- 05: US FDA reminds Ranbaxy to ensure standards in all facilities manufacturing for US market
- 05: Palomid 529 to cure age-related vision loss reaches Phase I trials, says Paloma
- 05: Fidaxomicin has an edge over Vancocin to treat clostridium infection: Optimer
- 05: Bayer joins hands with Biocon to promote blood glucose meter Breeze2 in India
- 04: GSK’s blood-stage malaria vaccine evokes strong immune response in children
- 04: Oral pill to treat cystic fibrosis VX-809 by Vertex in human trials
- 04: Sequenom launches non-invasive Rh factor diagnosis test SensiGene Fetal RHD Genotyping
- 04: Nitroglycerin can stop prostate cancer tumour growth, claims Queens study
- 04: A1c blood test can be additional diagnostic criterion for type 2 diabetes: American endocrinologists
- 03: Ingenol mebutate (PEP005) gel to treat actinic keratosis leading to skin cancer is nearing approval: Leo Pharma
- 03: Sex hormone androgen-based prostate cancer therapy risks heart disease: Study
- 03: Cancer, HIV/AIDS drugs may go cheaper in India
- 02: Nitazoxanide (Alinia) could overcome drug-resistance in influenza, says Romark
- 02: C5aR-targeting autoimmune diseases drug shows promise: ChemoCentryx
- 02: ECI Biotech’s ExpressDetect to measure bacterial level in wounds recieves SBIR grant
- 02: Ring worm of the nail (onychomycosis) drug luliconazole may go on clinical trials this year: Topica
- 02: Natural anti-cancer drug with no side-effect by EcoBiotics is coming
- 01: Sun Pharma’s Q3 2010 profits drops due to lower sales in US
- 01: Indoco to supply generics to Watson Pharma in US
- 01: Stem cell stimulation therapy NTx-265 to treat traumatic brain injury gets Canadian approval: Stem Cell Therapeutics
- 01: Tobacco-based vaccine to treat non-Hodgkin’s lymphoma by Bayer in human trials
- 01: HIV drug didanosine can cause fatal liver disease, warns US FDA
January 2010
- 29: Specialties, formulations sales boost Glenmark’s Q3 FY 2010 net by 15%
- 29: DCGI denies permission for Cadila Pharma to conduct trials on H1N1 swine flu vaccine: Report
- 29: Chikungunya vaccine may be around the corner
- 29: India enforces stricter norms for pharma exporters: Reports
- 29: First Response, early pregnancy prediction home test kit approved for sale in US: Church & Dwight
- 28: Trovan vaccine clinical trial victims in Kano to get N26,250,000 for death, injury from Pfizer
- 28: Cipla’s third quarter net up by 30%
- 28: Cytokinetics’ CK-2017357 shows promising in amyotrophic lateral sclerosis (ALS), myasthenia gravis
- 28: Cord blood stem cell banking centres in India
- 28: PathCare Labs launches ‘Cord Care’ – cord blood stem cell bank in India
- 27: Amitriptyline, ketamine combo NP-1 to treat neuralgia gets speedier review in US: EpiCept
- 27: Blood test for early detection of HIV infection Architect HIV Ag/Ab Combo assay under review in US
- 27: Bavarian Nordic’s Prostvac-VF vaccine extends life-time in prostate cancer patients
- 27: India opens medical devices production park in Chennai
- 27: Environmental pollution risk high in Indian pharma manufacturing factories: Study
- 26: Autism drug CM-AT by Curemark reaches final phase of human studies
- 26: Nucleic acids siRNA therapy to treat cancer granted patent in China: MDRNA
- 26: Dry eye drug Prolacria (diquafosol) fails in trials: Inspire Pharma
- 26: Melody transcatheter valve a non-surgical option for congenital heart disease, says Medtronic
- 26: Insulin prices to go up in India
- 25: Pig brain cells NTCell to treat Alzheimer’s, multiple sclerosis granted patent in Europe, says Living Cell Tech
- 25: Sales of weight loss pill sibutramine could be prohibited in India
- 25: Cepheid’s test kit for hospital-acquired infections Xpert vanA reaches US market
- 25: Ampyra (dalfampridine) can help multiple sclerosis patients walk: Acorda
- 25: Nano drug ALX-0081 from Ablynx to open up blocked blood vessels coming
- 22: Jubilant Organosys to split agri & polymer business; posts Rs 100 crore profit for Q3 2010
- 22: Glenmark sees 180-day exclusive sales potential for trandolapril and verapamil (Tarka) generic
- 22: Biocon sees oral insulin pill rival as Oramed’s ORMD-0801 enters crucial clinical trial phase
- 22: Forest’s fibromyalgia drug Savella (milnacipran) can increase heart disease risk
- 22: Oral drug perifosine is safe to treat metastatic colon cancer: Keryx, AEterna Zentaris
- 21: Biocon’s Q3 net up by 187% as drug sales, contract services revenues peak
- 21: Appendicitis could be a viral infection, says study
- 21: Once-daily pill LX4211 controls blood sugar in four weeks, says Lexicon
- 21: BioNumerik’s Tavocept extends survival in lung cancer patients
- 21: C-Reactive Protein infection test Piccolo, says Abaxis
- 20: betapharm write-down hurts Dr Reddy’s Q3 FY 2010 net profits
- 20: US FDA revokes ban on Lupin’s Mandideep facility; grants tentative approval for generic memantine (Namenda) pills
- 20: Orally inhaled migraine drug dihydroergotamine (Levadex) is safer, fast-acting, says Map Pharma
- 20: India may begin H1N1 swine flu vaccination drive by March; Sanofi-Pasteur vaccine only by Feb
- 20: Bharat Biotech joins race of Indian H1N1 swine flu vaccine makers by developing cell culture HN-VAC
- 20: RX-3117 can overcome cancer drug gemcitabine resistance: Rexahn
- 19: India plans large animals facility involving dogs and monkeys for drug testing
- 19: K J Yesudas files writ petition in Kerala High Court to make life-saving drugs affordable for poor
- 19: Korean scientists develop herbal pill KIOM-C to treat H1N1 swine flu
- 19: wilate to treat bleeding disorder von Willebrand disease to be launched in US: Octapharma
- 18: H1N1 swine flu vaccine prices to dip in India as more companies join fray
- 18: Blood test to detect ovarian cancer human epididymis protein 4 (He4) gets EU approval : Abbott
- 18: Omega 3 fatty acid-based ethyl icosapentate (AMR 101) to lower high triglycerides level may soon hit market: Amarin Corp
- 18: Ustekinumab (Stelara) effective in plaque psoriasis: Janssen-Cilag
- 18: Indian pharma firms claim one third of generics approved in US market in 2009
- 15: Stem cell therapy IND 13729 for amyotrophic lateral sclerosis (ALS) in clinical trials: TCA Cellular
- 15: Intercept extends platelet storage time upto 7 days, says Cerus
- 15: 3-D dental imaging machine Kodak 9500 3D launched in India: Carestream Health
- 15: Oral pill to cure age-related vision loss macular degeneration ACU-4429 is undergoing clinical studies: Acucela
- 15: Non-surgical treatment for uterine fibroids ExAblate System by InSightec approved in Japan
- 14: Biocon plans clinical studies on oral insulin pill IN 105 in US
- 14: Artificial pancreas to control blood sugar levels in type 1 diabetes coming
- 14: India to conduct on-the-spot inspections on clinical trial sites from July: Reports
- 14: Gardasil prevents cervical, vaginal cancers in women of 27-45 age group too: Merck
- 14: Palsy drug davunetide gets Orphan Drug Designation in US, says Allon Therapeutics
- 13: Wockhardt gets tentative approval for generic levofloxacin pills (Levaquin) in US
- 13: Safer yellow fever vaccine is currently in clinical studies: Xcellerex
- 13: Biological E joins hands with VaxInnate Corp to launch recombinant H1N1 swine flu vaccine in India
- 13: Long acting oral insulin pill NN9924 in clinical studies: Novo Nordisk
- 13: Fast-acting erectile dysfunction drug avanafil beats rival Viagra: Vivus
- 13: Magnetic catheter to correct abnormal heart rhythm approved in US: Stereotaxis
- 13: Vaccine to treat Pseudomonas pneumonia on way: Sanofi and KaloBios
- 13: Miglustat (Zavesca) may be approved in US to treat Niemann-Pick type C disease
- 13: Suven bags patents from China & Russia for neurodegenerative drug leads
- 12: Gene medicine for pancreatitis caused by lipoprotein lipase deficiency Glybera under review in Europe
- 11: Plastic surgery fat graft device PureGraft approved in US: Cytori
- 11: Serum Institute may launch nasal vaccine against H1N1 swine flu in India soon
- 11: Non-Hodgkin’s lymphoma vaccine BiovaxID to get fast-track review in US: Biovest
- 11: Nilotinib (Tasigna) of Novartis granted patent in India: Reports
- 11: Diabebetic neuropathy drug SB-509 by Sangamo Bio reaches crucial human trials
- 08: Orchid Pharma needs to resolve patent litigation with Forest Labs to sell memantine (Namenta) in US
- 08: Blood oxygenating device Hemolung to go on clinical studies in India: ALung Tech
- 08: Liposome paclitaxel found safe for advanced breast cancer in Indian clinical studies: NeoPharm
- 08: Indian H1N1 swine flu vaccine at Rs 50-100 per dose by March
- 08: Taxus Liberté stent by Boston Scientific is not safe in heart patients, says study
- 07: Wockhardt gets tentative approval for Alzheimer’s generic memantine (Namenda) in US
- 07: Letrozole for infertility treatment in young women could face a sales ban in India : Reports
- 07: Less-toxic picoplatin can beat platinum-resistance; safer to treat colorectal, prostate cancers: Poniard
- 07: Amifampridine phosphate to treat Lambert Eaton Myasthenic Syndrome (LEMS) gets EU marketing approval
- 07: Blood thinner prasugrel (Effient) cheaper to treat heart vessel blocks than clopidogrel (Plavix): Study
- 06: Doxorubicin prodrug INNO-206 cuts tumour size in advanced pancreatic cancer: CytRx
- 06: Gilead’s four drug single dose anti-HIV pill “quad” regimen shows promise
- 06: Biostar Pharma launches Chinese medicine to treat hepatitis B in Beijing and Shanghai
- 06: Once-daily schizophrenia drug lurasidone under FDA review in US: Dainippon Sumitomo Pharma
- 06: Pfizer strikes deal with Strides Arcolab on 40 generic products
- 05: Bio-Rad launches rheumatoid arthritis diagnostic test BioPlex 2200
- 05: Targeted oral pill INK128 can more effectively treat a variety of cancers: Intellikine
- 05: VBL’s oral pill to treat psoriasis VB-201 enters crucial phase of clinical trial
- 05: Fibrosis drug pirfenidone fast-tracked for approval in US, says Intermune
- 05: Anti-oxidant Protandim could treat alcohol related liver disease : LifeVantage
- 04: Santarus to study new drug rifamycin SV MMX in travelers’ diarrhea
- 04: DP-b99 can stop brain damage in stroke patients: D-Pharm
- 04: H1N1 swine flu infections to continue in India: Report
- 04: Balaglitazone cuts down HbA1c levels in clinical studies: Dr Reddy’s & Rheoscience
- 04: Ranbaxy bolsters dermatology portfolio by launching mycoses anti-fungal luliconazole (Lulifin) in India
- 01: Swine flu: India reports 26039 cases of H1N1 infections; 967 deaths till January 1, 2010
- 01: Vigabatrin (Sabril) for treatment-resistant epilepsy now available in US
- 01: Biodel seeks US FDA approval for mealtime insulin VIAject to treat diabetes
December 2009
- 31: Once-daily weight loss pill Qnexa by Vivus under regulatory review in US
- 31: Blood test to detect appendicitis AppyScore is coming: AspenBio Pharma
- 31: US FDA delays pneumococcal vaccine Prevnar 13 approval: Pfizer
- 31: Medicinal plants exports from India zoom
- 30: India to buy 1.5 million doses of H1N1 swine flu vaccine from Sanofi Pasteur: Reports
- 30: OTC lotion to treat cold sores NB-001 to enter US, Canada
- 30: New epilepsy drug retigabine under FDA review in US
- 30: Novo Nordisk’s diabetes drug liraglutide (Victoza) FDA approval delayed in US
- 30: STA-9090 highly promising in advanced gastrointestinal stromal tumours (GIST), says Synta
- 30: Ceftobiprole antibiotic to fight tougher bacterial infections fails to win approval in US
- 30: Pharmaxis’ lung function test Aridol rejected by US FDA
- 29: A1C diabetes diagnostic test is faster, easier: recommends ADA
- 29: Skin cancer melanoma vaccine Allovectin-7 data promising, says Vical
- 29: New target for epithelial cancers identified: Compugen
- 29: Human hand, foot and mouth disease vaccine (EnteroVirus EV 71) in clinical trials: Sinovac
- 28: India bans import and sale of weight loss pill rimonabant
- 28: Zolpimist spray to induce faster sleep in insomnia gets FDA approval in US:NovaDel
- 28: Lorcaserin, safer drug for weight-loss management by Arena soon
- 28: Depomed files another suit against Lupin in US court on Glumetza (metformin) generic
- 28: MDY-1001 polymer drug to protect intestines from radiation therapy damage from Midway Pharma
- 25: Sepsis drug eritoran safe in humans: Eisai
- 25: US FDA slaps warning letter on Ranbaxy’s liquids manufacturing unit Ohm Labs
- 25: Sun Pharma to sell generic imatinib (Gleevec) in US
- 25: High-dose flu vaccine Fluzone for elderly approved by US FDA: Sanofi Pasteur
- 25: Corticotrophin (Acthar) to cure infantile spasms under FDA review in US: Questcor
- 25: Diabetic retinopathy blindness drug Iluvien (fluocinolone) improves vision: Alimera
- 24: Glenmark gets a booster dose from pramipexole (Mirapex) and atomoxetine (Strattera) generic approvals in US
- 24: India may develop gene-based medicines specific and affordable to population
- 24: Painless surgical device CyberKnife to cure cancer launched in India by HCG
- 24: Wrinkle drug azficel-T (Laviv) by Fibrocell needs more data for approval: US FDA
- 24: Anti-rabies vaccine shortage in India may worsen as High Court stays Verorab supply
- 23: Non surgical option to gastric bypass Endobarrier Gastrointestinal Liner to control diabetes, obesity win EU approval: GI Dynamics
- 23: Invisible hearing loss aid Esteem Hearing Implant to hit US market soon: Envoy Medical
- 23: H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca’s MedImmune
- 23: ReNeuron’s stem cell line ReN001 to treat disabled stroke patients in human trials
- 22: Instant info on blood sugar trends now possible by Contour USB glucose meter
- 22: Teva recalls all lots of ketamine injection CIII 100mg/mL in 10mL vials for animal use in US
- 22: Oversleeping pill Nuvigil’s (armodafinil) approval delayed in US: Cephalon
- 22: Zegerid OTC pill to treat heartburn approved by US FDA
- 22: Oasis Infotech joins hands with Maventic to provide LIMS solutions for pharma, healthcare firms
- 22: Lenalidomide (Revlimid) extends disease-free survival in multiple myeloma patients: Study
- 22: Diffuse large B-cell lymphoma drug pixantrone may get a quicker review in Europe
- 21: H1N1 swine flu detection test TessArray RM-Flu cleared for emergency use by US FDA
- 21: Insulin nasal spray Nasulin can lower glucose levels faster: CPEX
- 21: Oseltamivir (Tamiflu) approved to prevent H1N1 swine flu in infants in Japan
- 18: ANA598 combo cuts down hepatitis C virus to undetectable levels: Anadys
- 18: Dr Reddy’s loses schizophrenia drug Zyprexa generic litigation to Eli Lilly in UK
- 18: GSK’s Cervarix ad campaign promoting cervical cancer vaccine under Indian drug regulator’s scanner
- 18: India’s new TB drug Risorine could cut down rifampicin use, treatment time
- 18: Schizophrenia drug zicronapine shows better safety profile in human studies: Lundbeck
- 17: Chinese herbal Jin Hua Qing Gan Fang found curing H1N1 swine flu in clinical studies, say reports
- 17: Brain injury drug KN38-7271 increases survival: KeyNeurotek
- 17: Non-surgical procedure Keraflex could cure keratoconus without damaging cornea: Avedro
- 17: Suicide risk higher in epilepsy drugs carbamazepine (Tegretol); divalproex sodium (Depakote), gabapentin (Neurontin), Levetiracetam (Keppra), Pregabalin (Lyrica): FDA
- 17: Aurobindo’s seasonal allergic rhinitis generic cetirizine (Zyrtec) syrup wins US FDA approval
- 16: Philips to set up sleep labs in leading Indian hospitals and clinics
- 16: Jubilant Organosys boosts niacinamide (Vitamin B3) production capacity
- 16: Xiaflex to treat curved penis (Peyronie’s disease) found safe in studies: Auxilium
- 16: Alzheimer’s drug ELND005 or scyllo-inositol trials suffer setback as 9 patients die: Elan and Transition
- 16: Vaccine against gum disease periodontitis (pyorrhea) is in clinical studies: CSL
- 15: Women more likely to get cancer from CT scans than men: Study
- 15: Sanofi’s H1N1 2009 swine flu vaccine batches recalled in US following drop in potency
- 15: Hospira boosts generic injectables portfolio by acquiring Orchid’s formulation business
- 15: Aurobindo’s depression pill citalopram approved in Australia
- 15: Inhaled, fast-acting loxapine to treat schizophrenia agitation to be reviewed by US FDA: Alexza
- 14: Sex hormone drugs Premarin and Prempro of Wyeth lead to cancer in women
- 14: Anti-HIV gel PRO 2000 fails to prevent infection in African women
- 14: Laromustine (Onrigin) needs more data to prove safety, says US FDA; Vion faces liquidation
- 14: Suven Life wins Canadian patents for drug leads to treat neurodegenerative diseases
- 14: India to try more effective vaccine bOPV to eradicate polio
- 11: Prostate drug tamsulosin (Flomax) generic to be launched in US by March 2010 : Daiichi-Ranbaxy
- 11: Triple negative breast cancer drug BSI-201 may get speedier review in US : Sanofi Aventis
- 11: Needle-free vaccine for traveller’s diarhoea on way
- 11: Biocon to start clinical studies for cervical cancer drug BIOMAb EGFR in India
- 11: MNC pharma firms line up to tap India’s rural market
- 09: Insulin spray Oral-lyn acts faster than injections : Generex
- 09: Vaccine to target breast, ovarian and prostate cancers in clinical trials: Immunovaccine
- 09: Dengue fever vaccine trail expanded to more Latam countries: Sanofi Pasteur
- 09: Endometriosis drug Visanne (dienogest) to be launched in Europe soon: Bayer Schering
- 09: ACG Worldwide opens facility for barrier packaging films
- 08: Alka-Seltzer Plus cold remedy by Bayer recalled in US
- 08: Nilotinib (Tasigna) to beat myeloid leukemia drug Glivec (imatinib) coming
- 08: Oseltamivir (Tamiflu) may not cure H1N1 swine flu complications: Report
- 08: Oral anticoagulant rivaroxaban (Xarelto) cuts deep vein thrombosis risk by 82%: Bayer
- 08: H1N1 swine flu vaccines Pandemrix and Celvapan may be launched in India soon
- 07: India to boost pharma trade with Russia
- 07: Novo Nordisk begins clinical studies of insulin pill even as India’s Biocon lines up oral insulin for launch
- 07: Oxycodone (OxyContin) led to five-fold increase in deaths in Canada: Report
- 07: Olanzapine (Zyprexa) approved by FDA to treat schizophrenia in adolescents
- 07: Eculizumab (Soliris) cuts blood clot risk in rare blood disorder PNH: Alexion
- 04: Serum to launch late phase human trials on inhalable measles vaccine in India
- 04: HIV drug fosamprenavir (Lexiva) raises cholesterol; could lead to heart disease
- 04: Merck’s anti-fungal caspofungin (Cancidas) to carry warning on liver problems in kids
- 04: TSO3 Sterizone appoved to sterilize endoscopes by US FDA
- 04: Weight-loss pill sibutramine (Meridia) may face ban in US
- 03: Everolimus not useful in women with kidney transplants: US FDA
- 03: Libido boosting testosterone injection Aveed by Endo requires more safety data: US FDA
- 03: ACG joins hands with Korsch to make cost-effective tabletting machines in India
- 03: Polymer-free drug eluting balloon technology ‘SeQuent Please’ launched in India: B Braun
- 03: India is 3rd largest producer of pharmaceuticals in the world: Minister
- 02: Alzheimer’s detection agent florbetaben in late phase studies
- 02: Valproic acid could treat polycystic kidney disease: Study
- 02: Novavax reports positive data from H1N1 swine flu vaccine trials; Cadila Pharma gets a booster
- 02: Muscle weakness disease LEMS drug 3,4-DAP may get speedier review in US: BioMarin
- 02: Once-weekly taspoglutide works better than sitagliptin (Januvia) in type 2 diabetes: Roche
- 01: Pfizer to enter generic market in Japan; India’s Cipla in supply deal talks: Reports
- 01: Portable eye imaging device OIS EyeScan gets US FDA approval: Ophthalmic Imaging Systems
- 01: Mysterious virus causing crippling, months-long joint pain strikes Bangalore: Report
- 01: A third wave of H1N1 swine flu in the offing?
- 01: Indian HIV/AIDS vaccine in critical phase of human studies
- 01: Stavudine generic makers from India hit a roadblock as WHO strikes out drug from HIV therapy list
November 2009
- 30: Suven secures 3 European patents for neurodegenerative drug leads
- 30: Indian pharmaceuticals market will grow 10-14%; to touch $40 billion by 2015: Mckinsey
- 30: Melanoma drug PV-10 increases overall survival rates in patients: Provectus
- 30: Serum, Panacea & Bharat Bio to launch H1N1 swine flu vaccines in India early next year
- 27: Generics to grow faster in Central and Eastern European market in next 2 years: PMR
- 27: Sildenafil intravenous injection (IV) Revatio approved in US to treat pulmonary hypertension
- 27: 3167 children enrolled in biggest rotavirus vaccine trials in South Africa : Synexus
- 27: Drug to improve cognition in Alzheimer’s patients Lu AE58054 in human studies : Lundbeck
- 27: Teva used Big Pharma’s tactic to block galtiramer (Capaxone) generic in US, Natco says
- 26: Non-hormonal drug Lysteda (tranexamic acid) approved to treat heavy menstrual bleeding: Xanodyne
- 26: Reboxetin (Edronax, Vestra) has little benefit in depression treatment : IQWiG
- 26: Ranbaxy may spin $200 million on 180-day exclusive sales of valaciclovir generic pills: Analysts
- 26: Dimedon (latrepirdine) for Alzheimer’s could be a breakthrough drug: Study
- 26: Sun Pharma’s generic atomoxetine pills (Strattera) wins tentative approval from US FDA
- 25: South Korea drops plan to buy 3 million doses Glaxo’s H1N1 swine flu vaccine: Report
- 25: Biotherapeutics to propel contract manufacturing in India and China : Report
- 25: Shire to supply velaglucerase alfa free for Gaucher disease patients, initially
- 25: Avastin for colorectal cancer rejected again in UK; Erbitux stands to gain
- 25: Hepatitis C drug Albinterferon alfa-2b nearing FDA approval in US: Human Genome Sciences
- 25: ARCA’s heart failure treatment Gencaro (bucindolol) may get faster US FDA approval
- 24: Japanese health officials to fly Canada; no change in plan to import H1N1 swine flu vaccine Pandemrix
- 24: GVK Bio teams up with Bayer Cropscience in discovery chemistry
- 24: Teva may lose patent case on Famvir (famciclovir) herpes drug generic to Novartis: Report
- 24: India to extend drug reactions monitoring programme to all medical colleges
- 24: Jubilant Organosys partners with UAB and Southern Research on drug discovery
- 23: Vaginal progesterone gel is equally effective as hormone injection in infertility treatment: Study
- 23: Cytomegalovirus vaccine TransVax trial data promising: Vical
- 23: Aurobindo boosts non-betalactam formulations capacity
- 23: More dangerous, oseltamivir-resistant H1N1 swine flu strain reported in EU, US
- 23: Meridia (sibutramine) by Abbott risks heart disease in obese patients, says US FDA
- 20: GlaxoSmithKline recalls a lot of H1N1 vaccine Pandemrix from Canada due to side-effects
- 20: New drug increases intercourse time by 6-fold; delays orgasm: Sciele
- 20: Corifollitropin alfa (Elonva) to treat female infertility recommended for approval in EU: Merck
- 19: Sun Pharma gets US nod for Nicardipine Hydrochloride Injections (HCI) for hypertension
- 19: Contraceptive vaginal ring NuvaRing launched in India
- 13: Daiichi-Ranbaxy to supply Nuvo’s wound healing agent Oxoferin in Asian countries
Fatal error: Allowed memory size of 33554432 bytes exhausted (tried to allocate 77 bytes) in /home/dance33/public_html/pillscribe/wp-includes/functions.php on line 3074